Kronox Lab IPO

Kronox Lab Sciences Ltd

₹14,190 /110 sharesMinimum Investment

Kronox Lab IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
--₹136.00₹164.95₹28.95 (21.29%)

Kronox Lab IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
3 Jun ‘24 - 5 Jun ‘24₹14,190110₹129 - ₹136
Issue SizeIPO Doc
130.15Cr
RHP PDF

Subscription rate

As of 05 Jun'24, 05:00 PM
Qualified Institutional Buyers89.03x
Non-Institutional Investor301.35x
Retail Individual Investor52.86x
Total116.44x

About the company

Kronox Lab Sciences Limited manufactures high specialty fine chemicals for diversified end user industries. The company manufactures these fine chemicals in various grades of particle sizes ranging from 10 mesh to 100 mesh. These are used mainly as (i) reacting agents and raw materials in the manufacturing of active pharmaceutical ingredients (APIs); (ii) excipients in pharmaceutical formulations; (iii) reagents for scientific research and laboratory testing; (iv) ingredients in nutraceutical formulations; (v) process intermediates and fermenting agents in biotech applications; (vi) ingredients in agrochemical formulations; (vii) ingredients in personal care products; (viii) refining agents in metal refineries; and (ix) ingredients in animal health products, amongst others. The company also undertakes custom manufacturing of these products. The company has three manufacturing units located in Vadodara, Gujarat. These are close to the seaports of Mundra, Kandla, Hazira, and Nhava Sheva. These manufacturing units have an aggregate installed capacity of 7,242 tonnes per annum (TPA).;
Founded in
2008
Managing director
Mr. Jogindersingh Jaswal
Parent organisation
Kronox Lab Sciences Ltd

Strength and risks

Strengths
Risks
The company manufactures over 185 products spanning the phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, and gluconate families.
Its products are supplied to customers in India and more than 20 countries globally, including the US, Argentina, Mexico, Australia, Egypt, Spain, Turkey, UK, Belgium, UAE, and China.
The company’s products are used across a wide spectrum of industries, like pharmaceuticals, scientific and laboratory research, nutraceuticals, biotech, agrochemicals, personal care, metallurgy, and animal health.
Kronox Lab Sciences is a zero debt company with a history of over a decade of operations. The latter makes it easy for potential investors to study its past performance and estimate its future prospects.
For the financial years ended March 31, 2021, 2022, and 2023, the company’s total income increased from Rs 62.46 crore to Rs 82.25 crore to Rs 95.58 crore, while PAT rose from Rs 9.74 crore to Rs 13.54 crore to Rs 16.83 crore, respectively.

Financials

*All values are in Rs. Cr
No Graph Data To Display

Application details

Apply asPrice bandApply upto
Regular129 - 136₹2 Lakh
High Networth Individual129 - 136₹2 - 5 Lakh
For Kronox Lab IPO, eligible investors can apply as Regular.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW